Healthcare policy framework announcement with MFN drug pricing component. A-score: election(1-campaign promise), rule_of_law(1-normal policy process), separation(2-executive policy authority), civil_rights(2-healthcare access implications), capture(3-pharmaceutical industry interests), corruption(1-standard lobbying concerns), violence(0). Severity near baseline (framework stage, reversible, limited precedent). Mechanism modifier 1.15 for policy_change, scope 1.2 for federal/broad. Base 13.68→final 18.89. B-score: Layer1 moderate (outrage:3, meme:2, novelty:1, media:4)=5.5/10. Layer2 elevated (mismatch:4-details missing, timing:2, pivot:3, pattern:3)=5.4/12. Intentionality 6/15 (vague framework, no substance). Final 22.13. Classification: Both scores below 25 thresholds. Critical noise indicators present: framework without implementation details, unclear coverage provisions, announcement theater pattern. This is a policy proposal lacking concrete mechanisms for constitutional impact assessment. Noise score 0.72 reflects high announcement-to-substance ratio.